Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma

Clinical trial NCT00439465 · COMPLETED

Trial details

NCT number: NCT00439465
Sponsor: Dartmouth-Hitchcock Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myeloma Transplant-eligible Patients

Start date: 2007-01-01
Primary completion: 2012-10-15
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.